Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,294 | 70 | 95.8% |
| Education | $99.99 | 1 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $496.85 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $425.23 | 15 | $0 (2024) |
| GENZYME CORPORATION | $241.46 | 2 | $0 (2024) |
| Ardelyx, Inc. | $232.57 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $208.66 | 12 | $0 (2024) |
| Gilead Sciences, Inc. | $174.48 | 5 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $164.78 | 4 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $138.51 | 2 | $0 (2024) |
| Madrigal Pharmaceuticals | $114.94 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $91.90 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,745 | 57 | Janssen Biotech, Inc. ($425.23) |
| 2023 | $648.60 | 14 | ABBVIE INC. ($309.28) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.43 | General |
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $94.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.44 | General |
| 09/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $114.94 | General |
| Category: LIVER DISEASE | ||||||
| 08/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.41 | General |
| 07/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/02/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Immunology | ||||||
| 07/02/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 05/21/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.75 | General |
| Category: THERAPY FOR CSID | ||||||
| 05/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 33 | 33 | $7,668 | $1,610 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 18 | $6,198 | $1,406 | 22.7% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 15 | 15 | $1,470 | $203.67 | 13.9% |
About Avery Lebowitz, APNP
Avery Lebowitz, APNP is a Acute Care healthcare provider based in Menasha, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2023. The National Provider Identifier (NPI) number assigned to this provider is 1619675790.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Avery Lebowitz, APNP has received a total of $2,394 in payments from pharmaceutical and medical device companies, with $1,745 received in 2024. These payments were reported across 71 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,294).
As a Medicare-enrolled provider, Lebowitz has provided services to 33 Medicare beneficiaries, totaling 33 services with total Medicare billing of $1,610. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Menasha, WI
- Active Since 02/20/2023
- Last Updated 02/20/2023
- Taxonomy Code 363LA2100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619675790
Products in Payments
- DUPIXENT (Biological) $333.36
- IBSRELA (Drug) $232.57
- STELARA (Biological) $223.04
- ENTYVIO (Biological) $208.66
- TREMFYA (Drug) $202.19
- VOQUEZNA (Drug) $164.78
- SKYRIZI (Biological) $147.82
- OCALIVA (Drug) $138.51
- REZDIFFRA (Drug) $114.94
- RINVOQ (Biological) $108.87
- Epclusa (Drug) $95.61
- LINZESS (Drug) $79.30
- SUCRAID (Drug) $42.71
- MAVYRET (Drug) $26.78
- HUMIRA (Biological) $24.22
- XELJANZ (Drug) $23.13
- Linzess (Drug) $20.43
- CYLTEZO (Drug) $18.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.